- Home
- CBUS vs MCN Comparison
CBUS vs MCN Comparison
Compare CBUS & MCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBUS | MCN |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.2M | 112.5M |
| IPO Year | 2017 | 2004 |
Fundamental Metrics
Financial Performance| Metric | CBUS | MCN |
|---|---|---|
| Price | $1.32 | $5.30 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.33 | N/A |
| AVG Volume (30 Days) | ★ 104.9K | 61.0K |
| Earning Date | 11-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.96% |
| EPS Growth | ★ 74.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,639,000.00 | N/A |
| Revenue This Year | $42.75 | N/A |
| Revenue Next Year | $139.28 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $5.18 |
| 52 Week High | $4.19 | $6.20 |
Technical Indicators
Market Signals| Indicator | CBUS | MCN |
|---|---|---|
| Relative Strength Index (RSI) | 33.60 | 39.11 |
| Support Level | $1.22 | $5.18 |
| Resistance Level | $1.62 | $5.69 |
| Average True Range (ATR) | 0.12 | 0.06 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 9.80 | 51.22 |
Price Performance
Historical ComparisonAbout CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About MCN Madison Covered Call & Equity Strategy Fund
XAI Madison Equity Premium Income Fund is an investment management company. The Fund invests in an actively managed equity portfolio comprised of individual stocks and covered call options. The Fund's primary investment objective is to provide high level of current income and gains, with a secondary objective of capital appreciation.